Lu et al. Do variants of the FONG gene contribute to osteoporosis risk?

IBMS BoneKEy ◽  
2017 ◽  
Vol 14 ◽  
pp. 799
Keyword(s):  
Osteoporosis Risk

Influence of osteoporosis risk factors on extensive suppression of bone metabolism during antiresorptive therapy

2014 ◽  
Author(s):  
Tijana Icin ◽  
Jovanka Novakovic-Paro ◽  
Bojan Vukovic ◽  
Ivana Bajkin ◽  
Milica Medic-Stojanoska
Keyword(s):  
Risk Factors ◽  
Bone Metabolism ◽  
Antiresorptive Therapy ◽  
Osteoporosis Risk Factors ◽  
Osteoporosis Risk

scholarly journals Retraction Note: Associations between VDR Gene Polymorphisms and Osteoporosis Risk and Bone Mineral Density in Postmenopausal Women: A systematic review and Meta-Analysis

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Liang Zhang ◽  
Xin Yin ◽  
Jingcheng Wang ◽  
Daolinag Xu ◽  
Yongxiang Wang ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Systematic Review ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Gene Polymorphisms ◽  
Meta Analysis ◽  
Mineral Density ◽  
Vdr Gene ◽  
Vdr Gene Polymorphisms ◽  
Osteoporosis Risk

Editor's Note: this Article has been retracted; the Retraction Note is available at https://doi.org/10.1038/s41598-021-88654-1.

scholarly journals Effects of β-Cryptoxanthin on Improvement in Osteoporosis Risk: A Systematic Review and Meta-Analysis of Observational Studies

Foods ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 296
Author(s):  
Sun Jo Kim ◽  
Nguyen Hoang Anh ◽  
Nguyen Co Diem ◽  
Seongoh Park ◽  
Young Hyun Cho ◽  
...  
Keyword(s):  
Systematic Review ◽  
Hip Fracture ◽  
Bone Health ◽  
Observational Studies ◽  
Meta Analysis ◽  
Random Effects Model ◽  
High Intake ◽  
Quantitative Evidence ◽  
Osteoporosis Risk ◽  
Reduced Risk

Many studies have analyzed the effects of β-cryptoxanthin (BCX) on osteoporosis and bone health. This systematic review and meta-analysis aimed at providing quantitative evidence for the effects of BCX on osteoporosis. Publications were selected and retrieved from three databases and carefully screened to evaluate their eligibility. Data from the final 15 eligible studies were extracted and uniformly summarized. Among the 15 studies, seven including 100,496 individuals provided information for the meta-analysis. A random effects model was applied to integrate the odds ratio (OR) to compare the risk of osteoporosis and osteoporosis-related complications between the groups with high and low intake of BCX. A high intake of BCX was significantly correlated with a reduced risk of osteoporosis (OR = 0.79, 95% confidence interval (CI) 0.70–0.90, p = 0.0002). The results remained significant when patients were stratified into male and female subgroups as well as Western and Asian cohorts. A high intake of BCX was also negatively associated with the incidence of hip fracture (OR = 0.71, 95% CI 0.54–0.94, p = 0.02). The results indicate that BCX intake potentially reduces the risk of osteoporosis and hip fracture. Further longitudinal studies are needed to validate the causality of current findings.

scholarly journals Development and Internal Validation of the Male Osteoporosis Risk Estimation Score

2007 ◽  
Vol 5 (6) ◽  
pp. 540-546 ◽  
Author(s):  
A. J. Shepherd ◽  
A. R. Cass ◽  
C. A. Carlson ◽  
L. Ray
Keyword(s):  
Risk Estimation ◽  
Male Osteoporosis ◽  
Internal Validation ◽  
Osteoporosis Risk

Women’s perspectives and experiences on screening for osteoporosis (Risk-stratified Osteoporosis Strategy Evaluation, ROSE)

2014 ◽  
Vol 9 (1) ◽  
Author(s):  
Mette Juel Rothmann ◽  
Lotte Huniche ◽  
Jette Ammentorp ◽  
Reinhard Barkmann ◽  
Claus C. Glüer ◽  
...  
Keyword(s):  
Strategy Evaluation ◽  
Osteoporosis Risk
Sign in / Sign up

Export Citation Format

Share Document